Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE Guidelines of the French Society of Otorhinolaryngology. Role of the ENT specialist in the diagnosis of obstructive sleep apnea-hypopnea syndrome (OSAHS) in children. Part 2: Diagnostic investigations apart from sleep studies. 31202665

2019

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE A single-center retrospective study included 50 children (32 boys, 18 girls; mean age 5.5±2.3years) undergoing overnight RP in an ENT department between January and August 2016 for suspected OSAHS. 30880036

2019

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE Guidelines of the French Society of Otorhinolaryngology. Role of the ENT specialist in the diagnosis of childhood obstructive sleep apnea-hypopnea syndrome (OSAHS). Part 1: Interview and physical examination. 31202666

2019

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE A systematic review of four significant controversies in paediatric ENT was conducted from the available literature: tonsillectomy versus tonsillotomy, focusing on the evidence base for each; anaesthetic considerations in paediatric obstructive sleep apnoea surgery; the objective evidence for the benefits of surgical treatment for obstructive sleep apnoea; and the medical treatment options for residual obstructive sleep apnoea after surgical treatment. 29463325

2018

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE Their use in the setting of epilepsy or other seizure disorders is typically contraindicated.Case reportA 48-year-old patient with a history of poorly controlled epilepsy and obstructive sleep apnoea syndrome was referred for ENT review for possible tracheostomy. 30394239

2018

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE For the international panel, the ENT is a major player in the OSA diagnosis process. 29402674

2018

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE Paediatric obstructive sleep apnoea is a common clinical condition managed by most ENT clinicians. 29439747

2018

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE The authors present the guidelines of the French Society of ENT and Head & Neck Surgery (SFORL) on the role of the ENT physician in childhood obstructive sleep apnea-hypopnea syndrome (OSAHS). 29731297

2018

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE Between 1983-1993, the author led their ENT department of CHU Saint-Antoine to contribute in the knowledge of chronic snoring and Obstructive Sleep Apneas Syndrome (OSAS), and to define the treatment of their consequences. 27827006

2017

Entrez Id: 4907
Gene Symbol: NT5E
NT5E
CUI: C0520679
Disease: Sleep Apnea, Obstructive
Sleep Apnea, Obstructive
0.100 Biomarker BEFREE A multidisciplinary treatment team, which manages and treats OSAS, should include the dentist in addition to the sleep specialist and the ENT physician. 28681043

2017